Furthermore, in agreement with reduced ‘RAF’ protein-chaperone association and greater ‘RAF’ denaturation, treatment of the melanoma cells for 6 h with AR42 or with [pazopanib + AR42] reduced the total protein levels of B-RAF and RAF-1 (Figure 6E). The gene discussed is BRAF; the disease is melanoma.